Updates in the Treatment of Secondary AML After the 2024 SOHO Annual Meeting - Episode 2
James K. McCloskey, MD, and Harry P. Erba, MD, PhD, discuss factors to help determine intensive chemotherapy fitness in acute myeloid leukemia.